Netherlands· NL-8a675d13bbb3

Risedronaatnatrium Aurobindo 5 mg, filmomhulde tabletten

A risedronic acid product containing natriumrisedronaat 2,5-water, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC M05BA07

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about natriumrisedronaat 2,5-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Risedronic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC M05BA07 (risedronic acid), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search risedronic acid products by name

Risedronic acid · ATC M05BA07

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risedronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.45 in Italy to $1.17 in Switzerland — a ×2.6 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Risedronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.17
IT Italy$0.45

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: NATRIUMRISEDRONAAT 2,5-WATER
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: M05BA07
ATC class: Risedronic acid
Defined daily dose: 5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
106807

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

293 interactions on record for risedronic acid.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check risedronic acid against other medicines How interaction checks work

Risedronic acid · interactions on record

293 records

2 severe
68 moderate
204 info

Most severe, free to view

EtelcalcetideH05BX04severe
DeferasiroxV03AC03severe
Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate

19 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Risedronic acid in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risedronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Germany · Risedronat Al
France · Risedronate Eg
Italy · Risedronato Eg Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/8f7d2c68-9e8c-407c-87e6-f5eec269d20a
GET /v1/drugs/8f7d2c68-9e8c-407c-87e6-f5eec269d20a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106807_smpc.pdf",
  "strength": null,
  "atc_label": "Risedronic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106807",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NATRIUMRISEDRONAAT 2,5-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106807.pdf",
  "authorised_at": "2010/09/06",
  "procedure_number": "NL/H/2263/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "106807",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about risedronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console